Pharmaceutical Products · 13 pending regulations · $92.2M monthly imports · 100% from 1 countries · Updated daily from USITC
General
Free
Special
Free
Column 2
Free
Trade Agreement Eligibility
Monthly Imports
$92.2M
2026-01
Trade Concentration
100%
from top 3 of 1 origins
Regulatory Pressure
HIGH
0 rulings — · 13 reg · 0 cases
Global Rates
🇺🇸 Free
🇬🇧 United Kingdom: N/A · 🇪🇺 European Union: N/A · 🇨🇦 Canada: N/A · 🇧🇷 Brazil: N/A
Compare All →
Data compiled from USITC HTS, US Census Bureau, Federal Register · As of 2026-04-29 · Updates monthly
This code has elevated regulatory activity — 0 CBP rulings (0 in last 2 years, trend: stable), 13 pending Federal Register actions, and 0 CIT/CAFC cases.
100% of US imports for this code come from just 1 countries. High origin concentration increases exposure to trade disruptions or tariff escalations.
| Code | Description | Rate |
|---|---|---|
| 3003.39.50.00 | Other | Free |
| 3003.90.01 | Other | Free |
Request for comments and notice of public hearing.
Request for comments and notice of public hearing.
To Take Certain Actions Under the African Growth and Opportunity Act, and for Other Purposes
Institution of investigation and invitation to file written submissions.
MEDICAMENTS (EXCLUD GOODS OF 3002, 3005, OR 3006) CONTAING PENICILLINS OR DERIVATIVES THEREOF,OR STREPTOMYCINS OR THEIR DERIVATIVES
Census Bureau export classification matching this HTS import code.